Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07733921Completed
Randomised trial of triamcinolone acetonide and hypertonic saline in Seroma (3 arms), sponsored by Cairo University. Primary endpoint: Number of patients having seroma at 8 weeks. Started Nov 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07733921.